1. Suppression of tumorigenicity‐2 (ST2) is a promising biomarker in heart transplantation. Issue 5 (22nd February 2022) Authors: Galeone, Antonella; Salem, Joe‐Elie; Lebreton, Guillaume; Coutance, Guillaume; Nguyen, Lee; Hulot, Jean Sébastien; Atassi, Fabrice; Bega, Marco; Leprince, Pascal; Varnous, Shaida Journal: Clinical transplantation Issue: Volume 36:Issue 5(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗